ISRCTN75982397Active, not recruitingUnknown
Biomarkers and mechanisms of asthma remission following treatment with tezepelumab in adults with severe asthma – 3TR ABC
niversity of Leicester0 sites156 target enrollmentStarted: May 12, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 156
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Adult (=18 years old)
- •2. Clinical decision to initiate tezepelumab for severe asthma after meeting licensing, local and national guidelines
- •3. Be able to give valid written consent; compliant with study procedures and study visits
Exclusion Criteria
- •1. Known hypersensitivity to the active substance of tezepelumab or any of the excipients
- •2. Participation in an interventional clinical trial within 3 months of visit 1 or receipt of any investigational medicinal product within 3 months or 5 half-lives. Participation in other observational studies is acceptable if in the view of the investigator it will not impact the study outcomes
- •3. Other clinically significant medical disease or uncontrolled concomitant disease that is likely, in the opinion of the investigator, to require a change in therapy or impact the ability to participate in the study
Investigators
Similar Trials
Active, not recruiting
Unknown
Biomarkers of asthma remission after mepolizumab treatmentSevere asthmaRespiratoryAsthmaISRCTN47298476niversity of Leicester150
Active, not recruiting
Unknown
Biomarkers of asthma remission after dupilumab treatmentSevere asthmaRespiratoryISRCTN68147929niversity of Leicester150
Completed
Not Applicable
Juntendo University, Biomarker Discovery in AsthmaAsthmaJPRN-UMIN000009968juntendo university graduate school of medicine, Department of respiratory medicine300
Recruiting
Not Applicable
Elucidating pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress and the applicability to the individualized therapy for ACOasthma COPD ovarlap:ACO,asthma,COPDJPRN-UMIN000025329Department of Respiratory Medicine, Tohoku University Graduate School of Medicine150
Completed
Not Applicable
Genome wide association study on remission of asthma10006436asthmaNL-OMON36808niversitair Medisch Centrum Groningen119